Bone UltraSonic Scanner (BUSS): Validation Study

Completed

Conditions studied: Osteoporosis, Osteopenia

In brief

The aim of clinical study is to assess effectiveness of Bone UltraSonic Scanner (BUSS) versus densitometry (DXA) in osteoporosis detection.

Key facts

Study ID

NCT01439139

Run by

Artann Laboratories

People needed

130

Starts

2011-09-01

Expected to finish

2013-05-01

Last updated by the study team

2014-03-28

Who can join

Age: 50 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Postmenopausal
• Age 50-90 years
• Any race or ethnicity
• DXA spine and hip exam within one year

You may not qualify if…

• Open wounds or rashes on the testing area
• Active skin infection
• Recent tibia surgery
• Abnormal tibia anatomy
• Body Mass Index > 34.9 kg/m2
• Current or previous tibial fracture on side of testing
• Stroke or with total or partial paralysis with residual disability lasting more than 3 months
• Current or recent (within past 6 months) use of bone-active drugs:
• Bisphosphonates
• Calcitonin
• Estrogens or selective estrogen receptor modulator (SERM)
• Therapeutic doses of fluoride (> 2mg/day)
• Teriparatide used currently or within past 3 months
• Drugs under research protocols, and
• Unstudied or unapproved drugs
• Presence of metabolic bone disease

Where it is running

• Catholic Health System Affiliates & Sister's of Charity Hospital — Buffalo, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.